A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans

A pharmacological imaging challenge based on ¹¹C-buprenorphine PET-MRI to explore the response to opioids in humans

Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):3153-3154. doi: 10.1007/s00259-023-06253-w. Epub 2023 May 6.

Claire Leroy¹, Sébastien Goutal¹, Louise Breuil^{1

2}, Philippe Gervais¹, Hamza Cherkaoui^{1

3}, Philippe Ciuciu³, Sylvain Auvity^{1

2}, Dominique Vodovar^{1

2}, Claude Comtat¹, Vincent Lebon¹, Michel Bottlaender^{1

4}, Nicolas Tournier⁵

¹ Université Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401, Orsay, France.
² Université Paris Cité, Inserm UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, 75006, Paris, France.
³ Parietal Team, Université Paris-Saclay, CEA, Inria, 91190, Gif-Sur-Yvette, France.
⁴ Université-Paris-Saclay, UNIACT, Neurospin, CEA, 91191, Gif-Sur-Yvette, France.
⁵ Université Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401, Orsay, France. nicolas.tournier@cea.fr.

No abstract available